Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector
29/08/2019 11:25
Aug 29 (Reuters) - RepliCel Life Sciences Inc RP.V :
* REPLICEL LIFE SCIENCES RETAINS DERMATOLOGY SALES AND
MARKETING
EXECUTIVE TO GUIDE THE GLOBAL COMMERCIAL STRATEGY FOR ITS
AUTOMATED DERMAL INJECTOR
Source text for Eikon: ID:nCNWB42JBa
Further company coverage: RP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector